Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Petta

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Alimentary Pharmacology & Therapeutics|November 29, 2011
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver diseaseS Petta, M C Amato, V Di Marco, et al.
Alimentary Pharmacology & Therapeutics|April 25, 2007
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis CO Lo Iacono, G Venezia, S Petta, et al.
HIV Medicine|October 24, 2019
Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patientsG Sebastiani, S Cocciolillo, G Mazzola, et al.
The American Journal of Gastroenterology|October 6, 2011
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis CL Rizzo, Vincenza Calvaruso, B Cacopardo, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2015
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis CS Petta, E Vanni, E Bugianesi, et al.
Genes and Immunity|June 17, 2016
IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infectionK S O'Connor, S A Read, M Wang, et al.
Alimentary Pharmacology & Therapeutics|July 29, 2017
Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLDS Petta, V W-S Wong, C Cammà, et al.
Alimentary Pharmacology & Therapeutics|July 3, 2018
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis BR El Sharkawy, K Thabet, P Lampertico, et al.
Journal of Internal Medicine|December 28, 2017
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liverP Dongiovanni, S Stender, A Pietrelli, et al.
Alimentary Pharmacology & Therapeutics|August 10, 2017
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre studyG Cabibbo, S Petta, V Calvaruso, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Alimentary Pharmacology & Therapeutics|November 29, 2011
Visceral adiposity index is associated with significant fibrosis in patients with non-alcoholic fatty liver diseaseS Petta, M C Amato, V Di Marco, et al.
Alimentary Pharmacology & Therapeutics|April 25, 2007
The impact of insulin resistance, serum adipocytokines and visceral obesity on steatosis and fibrosis in patients with chronic hepatitis CO Lo Iacono, G Venezia, S Petta, et al.
HIV Medicine|October 24, 2019
Application of guidelines for the management of nonalcoholic fatty liver disease in three prospective cohorts of HIV-monoinfected patientsG Sebastiani, S Cocciolillo, G Mazzola, et al.
The American Journal of Gastroenterology|October 6, 2011
Comparison of transient elastography and acoustic radiation force impulse for non-invasive staging of liver fibrosis in patients with chronic hepatitis CL Rizzo, Vincenza Calvaruso, B Cacopardo, et al.
Alimentary Pharmacology & Therapeutics|March 25, 2015
PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis CS Petta, E Vanni, E Bugianesi, et al.
Genes and Immunity|June 17, 2016
IFNL3/4 genotype is associated with altered immune cell populations in peripheral blood in chronic hepatitis C infectionK S O'Connor, S A Read, M Wang, et al.
Alimentary Pharmacology & Therapeutics|July 29, 2017
Serial combination of non-invasive tools improves the diagnostic accuracy of severe liver fibrosis in patients with NAFLDS Petta, V W-S Wong, C Cammà, et al.
Alimentary Pharmacology & Therapeutics|July 3, 2018
A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis BR El Sharkawy, K Thabet, P Lampertico, et al.
Journal of Internal Medicine|December 28, 2017
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liverP Dongiovanni, S Stender, A Pietrelli, et al.
Alimentary Pharmacology & Therapeutics|August 10, 2017
Is early recurrence of hepatocellular carcinoma in HCV cirrhotic patients affected by treatment with direct-acting antivirals? A prospective multicentre studyG Cabibbo, S Petta, V Calvaruso, et al.
Pageof 5